These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Lipoprotein disorders in diabetes mellitus. Brown WV Med Clin North Am; 1994 Jan; 78(1):143-61. PubMed ID: 8283928 [TBL] [Abstract][Full Text] [Related]
11. Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor. Iwasaki T; Takahashi S; Takahashi M; Zenimaru Y; Kujiraoka T; Ishihara M; Nagano M; Suzuki J; Miyamori I; Naiki H; Sakai J; Fujino T; Miller NE; Yamamoto TT; Hattori H Endocrinology; 2005 Aug; 146(8):3286-94. PubMed ID: 15878964 [TBL] [Abstract][Full Text] [Related]
12. Diabetic dyslipidaemia: from basic research to clinical practice. Taskinen MR Diabetologia; 2003 Jun; 46(6):733-49. PubMed ID: 12774165 [TBL] [Abstract][Full Text] [Related]
13. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Vergès BL Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991 [TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia, atherosclerosis, and diabetes. Steiner G Prim Care; 1978 Mar; 5(1):81-9. PubMed ID: 206921 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of Secondary Hyperlipidemia due to Diabetes]. Yanai H Rinsho Byori; 2016 May; 64(5):508-512. PubMed ID: 30695359 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646 [TBL] [Abstract][Full Text] [Related]
17. [Diabetic dyslipidaemia and the atherosclerosis]. Márk L; Dani G Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274 [TBL] [Abstract][Full Text] [Related]